Opioid-Free Anaesthesia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
Lignocaine, Dexmedetomidine, Sevoflurane, Paracetamol, ParecoxibN/ASmall Molecule1 trial
Active Trials
NCT05681429Completed25Est. Jan 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Fresenius KabiLignocaine, Dexmedetomidine, Sevoflurane, Paracetamol, Parecoxib

Clinical Trials (1)

Total enrollment: 25 patients across 1 trials

NCT05681429Fresenius KabiLignocaine, Dexmedetomidine, Sevoflurane, Paracetamol, Parecoxib

Accelerated Recovery Following Opioid-free Anaesthesia in Supratentorial Craniotomy

Start: Jan 2023Est. completion: Jan 202425 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space